Download Time Session Presentation Time Session Time Session

Time
Session
Presentation
Opening
9:00-9:30
C.Zielinski, G. Prager, L. Lemmens,
A. Stunt/G. Henning
Pathology of PDAC
9:30 - 10:00
Molecular Pathology (incl. tumor
evolution/heterogeneity) of PDAC
(09:30-10:00)
10:00-10:30
Tumor Microenvironment &
Immunoresponse in PDAC
I Esposito
Diagnosis of PDAC: liquid biopsy vs.
tissue biopsy
(10:00-10:30)
9:00-10:30
common
session
10:30-11:00
Time
Session
Presentation
Coffee Break
10:30-11:00
Does Radicality Count? ( incl.
R0/R1 resection, vessel
replacement)
Session
Presentation
K Spindler
Coffee Break
11:00-11:20
Time
Th Becker
Innovation in
treatment
10:30-11:00
Surgery, radiotherapy and chemotherapy
G Prager
11:00-11:45
Communications skills- Can we make more noise?
L Constable
11.45-12.25
European guidelines for pancreatic cancer: a perspective on
emerging strategies
M Unseld
11.45-12.30
Using evidence to shape the message
A Stunt
12:25-12:30
Wrap-up
L Lemmens
12:30-14.00
Lunch Break
12:30-14:00
Lunch Break
Symptoms and side effects of pancreatic cancer and treatment N AKYÜZ
14:00-14:45
Pancreatic cancer experience
11:00-11:45
11:00-12:30
(Peri-)operative
Management
12:30-14:00
Lunch Break
14:00-14:30
Adjuvant Treatment
11:20 - 11:55
Neoadjuvant chemotherapy
M Ducrieux
11:55 - 12:15
Neoadjuvant radiotherapy
A De Vries
12:15 - 12:30
All: Panel Discussion
Primetime for chemo-combination? H Riess
14:00-14.45
Symptoms and
Side effects
Symptoms and Side effects of pancreatic cancer and treatment
Should we treat LA-PDAC like
borderline resectable PDAC?
14:00-15:30
systemic treatment
in PDAC
Unmet needs
Ethics
'An ethical reflection'
G Prager/D Arnold
Coffee Break
14:00-15:30
15:30-16:00
16:00-16:30
16:30-18:00
common
session
C Leuckx
14.45-15.30
The best induction treatment in
mPDAC!
15:30-16:00
A Sa Cunha
Complications of pancreatic cancer
D O´Reilly
and treatment
Coffee Break
15:30-16:00
Coffee Break
Share 2 sessions with
Nurse Meeting
16:30-18:00
common
session
Time
Unmet needs
16:30-17:00
Role of early and controlled
palliative / symptomatic
management
17:00-17:45
Panel Discussion (doctor, nurses,
patient advocates)
N Hannon
17:45-18:00
Wrap-up - Conclusion of today
L Lemmens
Session
Presentation
Nal-Irinotecan as a new standard?
8:30-10:00
Emerging
Therapeutic
Strategies
Session
8:30-8:40
Introduction
8:40-9:15
End of life
Presentation
Time
L Lemmens
8:30-10:00
Best supportive care –
W Scheithauer
an holistic approach
Th Seufferlein
Role of nurses in a pancreatic cancer
setting
Coffee Break
10:30-12:00
Time
Session
Presentation
What informations do patients need
A Jewell
Diet and Nutrition
M De Pril
Optimal therapeutic sequence
Common
session
T Macarulla
2ndline treatment in
mPDAC
Platins as a good option
10:00-10:30
R Popescu
9:15-10:00
10:00-10:30
10:30-10:50
Immunotherapy and vaccinations
trials
M Ducreux
11:50-11:10
Advancing Precision Medicine
(druggable targets)
Th Seufferlein
11:10 -11:30
Active Chemo-combination Trials
D Arnold
11:30 - 12:00
Close-out
C.Zielinski, G.
Prager, L.
Lemmens, A.
Stunt/G. Henning
Nurse role
Coffee Break
M Philipps
Ph Whelan
10:00-10:30
10:30-12:00
Coffee Break